About: Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 October 2011

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2011 (uk) scientific article published on 12 October 2011 (en) 2011 թվականի հոկտեմբերի 12-ին հրատարակված գիտական հոդված (hy) artículu científicu espublizáu n'ochobre de 2011 (ast)
publication date	wds:Q85094818-1394C15A-CE3C-4BF2-8E40-B1F7F0E72C99
publication date	2011-10-12 00:00:00Z (xsd:dateTime)
author name string	wds:Q85094818-07B6C164-EA8F-4DE7-84EC-89CC82D637CB wds:Q85094818-290C6870-93D6-4516-A964-21D05D391109 wds:Q85094818-2F8787EA-B0B0-481B-9230-9F4FAED60D7C
author name string	Joshua G Petrie Emileigh Johnson Rachel T Cross
rdfs:label	Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (en) Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (nl)
skos:prefLabel	Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (en) Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (nl)
name	Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (en) Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (nl)
author	wds:Q85094818-8A6571B5-9E4B-49D7-ACF8-FCC26C4DAD3B wds:Q85094818-F7AEEB72-3057-414D-A832-44509AEF3871
author	Arnold S. Monto Suzanne E Ohmit
title	wds:Q85094818-27F16939-936E-4FD2-8300-36D0C2FA9272
title	Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection (en)
page(s)	wds:Q85094818-672C89BF-2E9F-45B0-A230-F1A76559C752
page(s)	1879-1885
instance of	wds:Q85094818-1D06CA95-5D2C-479A-9A3D-83A3E3403D2E
instance of	scholarly article
main subject	wds:Q85094818-19D10E20-FEA0-4368-8870-8D2FB5284E03
main subject	vaccine
PubMed ID	wds:Q85094818-AFE02E91-0DF4-40E9-A770-2D2371D541D6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21998477
PubMed ID	21998477
published in	wds:Q85094818-19D33A1E-B9B1-4036-8356-A70630945959
published in	Journal of Infectious Diseases
issue	wds:Q85094818-3B933BD9-1917-4577-8B38-3CD3291B6B53
volume	wds:Q85094818-933C7F3A-621B-4C58-B30E-2161A651CF31
issue	12
volume	204
DOI	wds:Q85094818-64A6FF40-AF2E-4534-84FD-A1C6D329EB9C
DOI	http://dx.doi.org/10.1093/INFDIS/JIR661
DOI	10.1093/INFDIS/JIR661
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q85094818
is cites work of	A non-adjuvanted whole-virus H1N1 pandemic vaccine is well tolerated and highly immunogenic in children and adolescents and induces substantial immunological memory Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination Heterosubtypic T-Cell Immunity to Influenza in Humans: Challenges for Universal T-Cell Influenza Vaccines Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults Do antibody responses to the influenza vaccine persist year-round in the elderly? A systematic review and meta-analysis A review of the changes to the licensing of influenza vaccines in Europe. Factors associated with maintenance of antibody responses to influenza vaccine in older, community-dwelling adults Influenza vaccine effectiveness in households with children during the 2012-2013 season: assessments of prior vaccination and serologic susceptibility Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials Systems vaccinology: probing humanity's diverse immune systems with vaccines Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-γ T cell responses in humans Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates Effects of Repeated Annual Inactivated Influenza Vaccination among Healthcare Personnel on Serum Hemagglutinin Inhibition Antibody Response to A/Perth/16/2009 (H3N2)-like virus during 2010-11. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons. The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial. Serological Correlates of Protection against a GII.4 Norovirus High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children. Influenza virus hemagglutinin stalk-based antibodies and vaccines Influenza virus exploits tunneling nanotubes for cell-to-cell spread Pathogen evolution and the immunological niche Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination. Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers Epitope specific T-cell responses against influenza A in a healthy population. Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens Risk factors of pandemic influenza A/H1N1 in a prospective household cohort in the general population: results from the CoPanFlu-France cohort. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins Waning vaccine protection against influenza A (H3N2) illness in children and older adults during a single season Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination Multivariate analysis of factors affecting the immunogenicity of trivalent inactivated influenza vaccine in school-age children Quantifying homologous and heterologous antibody titre rises after influenza virus infection An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection Preclinical evaluation of Vaxfectin-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088) Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines? Vaccination has minimal impact on the intrahost diversity of H3N2 influenza viruses Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial. The evolution of seasonal influenza viruses. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software